More results...
Details of financing structure to be reviewed by culture secretary and regulators before deal can proceedThe owner of the Daily Mail has secured funding for a £500m takeover of the Telegraph, in a crucial development that paves the way for the group to…
FTSE 100 miner’s U-turn follows investor opposition to payouts when deal completes, including estimated £8.5m to CEOBusiness live – latest updatesLondon-listed miner Anglo American has dropped plans to award its bosses multimillion-pound bonuses if its…
President vows to get involved in controversial takeover described as ‘unprecedented’ by ex-chair of regulatorBusiness live – latest updatesAnalysis: Netflix inks deal for troubled Hollywood giantDonald Trump has warned of potential competition problem…
Streaming service to gain control of studio behind Harry Potter and Batman, as well as HBO, home to The White Lotus and Game of Thrones Business live – latest updatesNetflix has agreed to buy Warner Bros Discovery in an $82.7bn (£62bn) deal that will d…
FTSE 100-listed miner forces Australian company to walk away from takeover after rebuffing second approach BHP has walked away from another attempt to take over rival miner Anglo American after it was again rebuffed, failing in a last-minute effort to…
Acquisition likely to trigger in-depth investigation by regulator after agreement between DMGT and Redbird IMIThe owner of the Daily Mail has struck a £500m deal to buy the Telegraph titles, in a move that will create a right-leaning publishing powerho…
Barclay family set to lose another part of former business empire, once known as Littlewoods, to Carlyle GroupThe Barclay family is set to lose control of another part of their former business empire with a US private equity firm taking control of onli…
US telecom firm Comcast aims to buy media and entertainment arm for £1.6bn but not Love Island maker ITV Studios• Business live – latest updatesITV has told the market it is in preliminary talks to sell its broadcasting arm to the parent company of Sky…
US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugsNovo Nordisk has launched a surprise $9bn (£6.9bn) offer for the US obesity-focused biotech firm Metsera that could gazump an existing bid from Pfizer as…
Court papers show Netherlands was warned in June that Nexperia might not be able to export to US with him in postUS authorities had raised concerns about the boss of a China-owned chipmaker before it was taken over by the Dutch government this week, ac…